Europe Artificial Organs & Bionics Market cover

Europe Artificial Organs & Bionics Market by Product (Artificial Organs and Bionics) and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: ICT-SE-2051
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 190
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Europe artificial organs & bionics market size is projected to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to growing incidence of renal diseases, acute renal failure, and the increasing organ failure due to ageing population.

Artificial organs are implanted in the body to replace the original organs if the natural organ fails or if any organ is destroyed by an external source such as an accident. Excessive blood loss, substance misuse, major trauma, and other acute illnesses are among the most common causes of organ failure. Furthermore, lifestyle problems such as poor eating habits, smoking, drinking too much alcohol, and not exercising enough are also important causes of organ failure.

 

Europe Artificial Organs & Bionics Market summary

Implantable devices with mechanical and electrical components are referred to as bionic implants. They may be divided into two categories biology and electronics. Additionally, there are enhanced robotic technologies. Artificial implants imitate the function of a missing or non-functional bodily component, such as a leg or an eye.

The Covid-19 pandemic affected the demand and supply of Europe artificial organs & bionics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

  • Growing incidence of renal diseases is projected to fuel the market during the forecast period.
  • Increasing elderly population is key factor propelling the market in the coming years.
  • Fear of device malfunction is estimated to hamper the market expansion.
  • Risk of artificial organ compatibility and their repercussions act as major challenge that can restrict the market expansion in the coming years.
  • R&D investment and technological advancement is anticipated to create lucrative opportunities for the market players.

Scope of the Report

The report on the Europe artificial organs & bionics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes         Details
Report Title Europe Artificial Organs & Bionics Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year 2020
Historic Data 2018–2019
Forecast Period 2021–2028
Segmentation Product (Artificial Organs and Bionics)
Geographical Scope Germany, United Kingdom, France, Italy, Spain, and Rest of Europe
Report Coverage        Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report Medtronic plc; Zimmer Biomet; Boston Scientific Corporation; Otto Bock Holding GmbH & Co. KG; Sonova Holding AG (Advanced Bionics)
 
 
 

Market Segment Insights

The cardiac bionics segment is projected to hold a major market share

Based on products, the Europe artificial organs & bionics market is divided into artificial organs and bionics. The cardiac bionics segment is expected to represent a key share of the market during the forecast period. Heart valves, ventricular assist devices, pacemakers, and other cardiac bionics are examples of cardiac bionics. The segment's rapid rise is attributed to  rising frequency of cardiovascular illnesses and the country's growing senior population. According to the European heart network, cardiovascular disease (CVD) kills 3.9 million people in Europe each year, with over 1.8 million people dying in the EU. AIDS, TB, and malaria together cause 46 times the amount of fatalities and 11 times the illness burden in Europe.

Germany is expected to dominate the market

On the basis of geography, the Europe artificial organs & bionics market is classified as Germany, United Kingdom, France, Italy, Spain, and Rest of Europe. Germany is anticipated to dominate the market during the forecast period. This is due to the region's vast technical developments and awareness of bionics and artificial organs' potential advantages.

Europe Artificial Organs & Bionics Market  geography

Segments

Segments Covered in the Report

The Europe artificial organs & bionics market has been segmented on the basis of

Product

  • Artificial Organs
  • Bionics

Geography

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe

Key Players

  • Medtronic plc
  • Zimmer Biomet
  • Boston Scientific Corporation
  • Otto Bock Holding GmbH & Co. KG
  • Sonova Holding AG (Advanced Bionics)

Competitive Landscape

Key players competing in the Europe artificial organs & bionics market include Medtronic plc, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Sonova Holding AG (Advanced Bionics).
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Europe Artificial Organs & Bionics Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs & Bionics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Organs & Bionics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Organs & Bionics Market - Supply Chain
  4.5. Global Artificial Organs & Bionics Market Forecast
     4.5.1. Artificial Organs & Bionics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Organs & Bionics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Organs & Bionics Market Absolute $ Opportunity
5. Global Artificial Organs & Bionics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Artificial Organs & Bionics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Artificial Organs & Bionics Demand Share Forecast, 2019-2026
6. North America Artificial Organs & Bionics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Artificial Organs & Bionics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Artificial Organs & Bionics Demand Share Forecast, 2019-2026
7. Latin America Artificial Organs & Bionics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Artificial Organs & Bionics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Artificial Organs & Bionics Demand Share Forecast, 2019-2026
8. Europe Artificial Organs & Bionics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Artificial Organs & Bionics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Artificial Organs & Bionics Demand Share Forecast, 2019-2026
9. Asia Pacific Artificial Organs & Bionics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Artificial Organs & Bionics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Artificial Organs & Bionics Demand Share Forecast, 2019-2026
10. Middle East & Africa Artificial Organs & Bionics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Artificial Organs & Bionics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Artificial Organs & Bionics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Artificial Organs & Bionics Market: Market Share Analysis
  11.2. Artificial Organs & Bionics Distributors and Customers
  11.3. Artificial Organs & Bionics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Medtronic plc
     11.4.2. Zimmer Biomet
     11.4.3. Boston Scientific Corporation
     11.4.4. Otto Bock Holding GmbH & Co. KG
     11.4.5. Sonova Holding AG (Advanced Bionics)

Segments Covered in the Report

The Europe artificial organs & bionics market has been segmented on the basis of

Product

  • Artificial Organs
  • Bionics

Geography

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe

Key Players

  • Medtronic plc
  • Zimmer Biomet
  • Boston Scientific Corporation
  • Otto Bock Holding GmbH & Co. KG
  • Sonova Holding AG (Advanced Bionics)

Key players competing in the Europe artificial organs & bionics market include Medtronic plc, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Sonova Holding AG (Advanced Bionics).
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Europe Artificial Organs & Bionics Market keyplayers

Buy Report